Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Serina Therapeutics (SER) has provided an announcement.
Tacey Viegas, the Chief Operating Officer of Serina Therapeutics, Inc., is set to retire on July 15, 2024. Upon his departure, he will receive his base salary and additional monthly compensation for a year, alongside a consulting agreement with the company to work on various projects. This agreement also extends the term of his stock options, reinforcing his ongoing connection with the company’s financial interests.
Find detailed analytics on SER stock on TipRanks’ Stock Analysis page.
